Treatment interruption
Sponsors
National Institute of Allergy and Infectious Diseases (NIAID), University Hospital, Geneva, French National Agency for Research on AIDS and Viral Hepatitis, SEARCH Research Foundation, Fundacion Clinic per a la Recerca Biomédica
Conditions
AIDSAcute HIV InfectionAntiretroviral Treatment InterruptionHIVHIV InfectionHIV Infections
Phase 2
A Study to Demonstrate That Anti-HIV Drug Therapy Can be Stopped Without Causing Viral Resistance, and to Characterize Drug Elimination From the Body
CompletedNCT00029341
Target: 36Updated: 2008-07-30
Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral Tx
CompletedNCT00071890
Start: 2003-10-31End: 2007-12-31Updated: 2010-10-05
Phase 3
Unknown Phase
Staccato: A Trial of CD4 Guided Treatment Interruption, Compared to Continuous Treatment, for HIV Infection
CompletedNCT00113126
Start: 2002-01-31End: 2005-10-31Target: 526Updated: 2006-11-29
Viral Suppression After Analytic Treatment Interruption in Thai Patients Who Initiated Highly Active Antiretroviral Therapy During Acute HIV Infection
CompletedNCT02614950
Start: 2016-02-29End: 2016-12-31Updated: 2017-01-27
A Clinical Trial of Analytical Treatment Interruption in People With HIV With a Highly Favourable Profile
Not yet recruitingNCT07875504
Start: 2026-10-01End: 2027-12-01Target: 20Updated: 2026-10-15